Uncertainty about usefulness of antiviral drugs in Ramsay Hunt syndrome
By ncbi.nlm.nih.gov
It seems logical that antiviral drugs might help patients with a herpes virus infection of the ear producing facial weakness (a condition known as 'Ramsay Hunt syndrome'). These drugs often help similar viral infections elsewhere in the body. However, trials that might address this issue have not been done and there is therefore some uncertainty about their usefulness. Since patients can experience side-effects when taking these drugs, the risks of these have to be balanced with the unknown prospect of benefit when considering whether to use them in Ramsay Hunt syndrome.
Background: Herpes zoster oticus (HZO) is a viral infection of the ear and when associated with acute facial paralysis is known as Ramsay Hunt syndrome. Antiviral agents are the standard first-line treatment for herpes zoster infections at other body sites and are thought to reduce or minimise nerve damage, thereby improving outcomes. It has been suggested that these agents improve the chance of facial weakness improving or resolving completely in patients with Ramsay Hunt syndrome.
Objectives: To determine the effectiveness of antiviral agents in the treatment of adult patients with Ramsay Hunt syndrome (HZO with facial palsy).
Search methods: We searched the Cochrane ENT Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, current issue), Medline (1950 - 2007), PubMed 2007 - 2008, EMBASE (1974 onwards) and other relevant databases. The date of the most recent search was June 2008.
Selection criteria: Two authors scrutinized all possible citations to identify randomised controlled trials in which antiviral agents alone or in combination with other therapies (using different routes of administration and dosage schemes) were given as treatment for Ramsay Hunt syndrome. We contacted an author for further information.
Data collection and analysis: Two reviewers independently assessed eligibility and trial quality.
Main results: Only one randomised, controlled trial was identified and included. It was of low quality and included only 15 participants. In this 1992 trial, intravenous acyclovir and corticosteroids were compared with corticosteroids alone. Our analysis found no statistically significant difference between the two groups.
Authors' conclusions: We found no evidence that anti-viral agents have a beneficial effect on outcomes in Ramsay Hunt syndrome, despite their widespread use in this condition. The use of these drugs in patients with herpes zoster infections in other parts of the body might suggest that they have a role in herpes zoster oticus. As usual, the absence of positive evidence of benefit (or, in this case, the 'negative' result of one small, statistically under-powered study) does not necessarily indicate that antivirals are ineffective. However, these drugs are associated with a number of adverse effects and this must be taken into consideration when undertaking the requisite risk-benefit analysis before instigating treatment.
Source: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0014179/
Wednesday, May 27, 2026
Fibromyalgia: Understanding Widespread Pain
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and often cognitive difficulties colloquially referred to as fibro fog. It affects approximately four million Americans and is more common in women. Despite being a real and significantly disabling condition, fibromyalgia has historically been misunderstood and underdiagnosed, leaving many patients without appropriate care for years. The exact cause of fibromyalgia is not fully understood, but research has established that it involves abnormal pain processing in the central nervous system, a phenomenon called central sensitization. In fibromyalgia, the brain and spinal cord amplify pain signals, causing the pain threshold to be significantly lower than in people without the condition. This explains why patients experience intense pain from stimuli that would be mild or non-painful for others, and why pain is widespread rather than localized to a specific damaged tissue. Triggers for fibromyalgia development or flares include physical trauma such as injury or surgery, infections, psychological stress, and hormonal changes. Sleep dysfunction, depression, anxiety, and irritable bowel syndrome frequently co-occur with fibromyalgia and share underlying neurobiological mechanisms. Diagnosis is clinical, based on widespread pain for more than three months and characteristic symptom patterns, after excluding other conditions that could explain the symptoms. For patients managing fibromyalgia alongside infections requiring antibiotic treatment, accessible care is available through https://www.amoxilcompharm.com/. Treatment of fibromyalgia is multimodal. Aerobic exercise is one of the most evidence-supported interventions and, despite the counterintuitive nature of exercising through pain, consistently reduces fibromyalgia symptoms when started gradually and progressed carefully. Cognitive behavioral therapy addresses the psychological components of chronic pain and teaches coping strategies. Medications including duloxetine, milnacipran, and pregabalin are FDA-approved for fibromyalgia treatment. Telehealth has proven particularly valuable for fibromyalgia care, providing regular access to support and treatment without the burden of travel that can itself be exhausting for patients with significant fatigue and pain. For comprehensive fibromyalgia information and chronic pain resources, visit https://amoxicillina.online/ for accessible patient guidance.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.